| Elizabeth Strager, | |
|
355 Cedar Springs Rd, Spartanburg, SC 29302-4628 | |
| (864) 585-7711 | |
| Not Available |
| Full Name | Elizabeth Strager |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 355 Cedar Springs Rd, Spartanburg, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205216298 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Provider Name | Comprehensive Therapeutics Ltd |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1437765583 PECOS PAC ID: 8921230137 Enrollment ID: O20201117000113 |
News Archive
Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) has cleared SpiderFX for the treatment of severely calcified lesions used in conjunction with plaque excision in arteries of the lower extremities. It is the only embolic protection device indicated for this treatment in the United States.
Healthy military personnel and muscular dystrophy patients are at opposite ends of the spectrum when is comes to muscle strength and resilience. However, a new University of Iowa study may provide insights that improve muscle health for both these groups.
Researchers from the University of Liverpool have identified a specific gene that plays a key role in an inherited eye disorder.
In this study, researchers report on the development of a monovalent lambda PLP-based vaccine against SARS-CoV-2 or MERS-Cov through decoration with the spike RBD proteins from either virus.
› Verified 4 days ago
| Provider Name | Dysphagia Management Systems Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1194196592 PECOS PAC ID: 4385920040 Enrollment ID: O20220427003298 |
News Archive
Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) has cleared SpiderFX for the treatment of severely calcified lesions used in conjunction with plaque excision in arteries of the lower extremities. It is the only embolic protection device indicated for this treatment in the United States.
Healthy military personnel and muscular dystrophy patients are at opposite ends of the spectrum when is comes to muscle strength and resilience. However, a new University of Iowa study may provide insights that improve muscle health for both these groups.
Researchers from the University of Liverpool have identified a specific gene that plays a key role in an inherited eye disorder.
In this study, researchers report on the development of a monovalent lambda PLP-based vaccine against SARS-CoV-2 or MERS-Cov through decoration with the spike RBD proteins from either virus.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Strager, 1058 Queens Dr, Moon Township, PA 15108-1376 Ph: (412) 430-2483 | Elizabeth Strager, 355 Cedar Springs Rd, Spartanburg, SC 29302-4628 Ph: (864) 585-7711 |
News Archive
Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) has cleared SpiderFX for the treatment of severely calcified lesions used in conjunction with plaque excision in arteries of the lower extremities. It is the only embolic protection device indicated for this treatment in the United States.
Healthy military personnel and muscular dystrophy patients are at opposite ends of the spectrum when is comes to muscle strength and resilience. However, a new University of Iowa study may provide insights that improve muscle health for both these groups.
Researchers from the University of Liverpool have identified a specific gene that plays a key role in an inherited eye disorder.
In this study, researchers report on the development of a monovalent lambda PLP-based vaccine against SARS-CoV-2 or MERS-Cov through decoration with the spike RBD proteins from either virus.
› Verified 4 days ago
Julie A Summers, M.S. CCC-SLP/L Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 104 Dillon Dr, Spartanburg, SC 29307 Phone: 864-948-9300 | |
Amaya Gunasekera, MCD, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2400 Winchester Pl Ste 102a, Spartanburg, SC 29301 Phone: 864-576-7188 | |
Jima Schaen Sparks, MCD CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1705 Skylyn Dr, Spartanburg, SC 29307 Phone: 964-582-6838 Fax: 864-585-9014 | |
Lauren Williams, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2400 Winchester Pl Ste 102, Spartanburg, SC 29301 Phone: 864-576-7188 | |
Kimberly Singleton, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2438 Scott St, Spartanburg, SC 29302 Phone: 864-285-0994 | |
Mrs. Charlise Yvette Anderson, M.C.D, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 916 Beverly Dr, Spartanburg, SC 29303 Phone: 864-573-9650 | |
Brooke Charping, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 355 Oak Grove Rd, Spartanburg, SC 29301 Phone: 864-595-4225 |